Institutional Ownership Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND). We have compiled data on the 270 institutions that hold shares in the stock, with a total of 61.9 Million shares, which have been reported (via 13F filing form) to have a value of $10 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Voloridge Investment Management, LLC
Jupiter, FL |
May 15, 2025 Q1 2025 |
346,018
shares
|
$54.4 Million
0.21% of portfolio
|
Q1 2025
Added 15.73%
|
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
343,390
shares
|
$54 Million
0.05% of portfolio
|
Q1 2025
Added 1.1%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
May 13, 2025 Q1 2025 |
330,153
shares
|
$51.9 Million
0.14% of portfolio
|
Q1 2025
Added 4.29%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
327,405
shares
|
$51.5 Million
0.1% of portfolio
|
Q1 2025
New holding
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
304,806
shares
|
$47.9 Million
0.33% of portfolio
|
Q1 2025
Reduced 4.04%
|
|
|
Siren, L.L.C.
New York, NY |
May 14, 2025 Q1 2025 |
287,366
shares
|
$45.2 Million
2.55% of portfolio
|
Q1 2025
Reduced 3.35%
|
|
|
Ars Investment Partners, LLC
|
May 14, 2025 Q1 2025 |
265,164
shares
|
$41.7 Million
4.55% of portfolio
|
Q1 2025
Reduced 0.12%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
264,867
shares
|
$41.7 Million
0.02% of portfolio
|
Q1 2025
Reduced 26.04%
|
|
|
Sei Investments CO
Oaks, PA |
May 14, 2025 Q1 2025 |
258,013
shares
|
$40.6 Million
0.05% of portfolio
|
Q1 2025
Reduced 2.16%
|
|
|
Q Global Advisors, LLC
Fort Worth, TX |
May 14, 2025 Q1 2025 |
248,887
shares
|
$39.1 Million
31.55% of portfolio
|
Q1 2025
Added 13.41%
|
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
242,761
shares
|
$38.2 Million
0.24% of portfolio
|
Q1 2025
Reduced 13.35%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2025 Q1 2025 |
216,000
shares
|
$34 Million
2.01% of portfolio
|
Q1 2025
Reduced 29.18%
|
|
|
New York State Common Retirement Fund
|
May 01, 2025 Q1 2025 |
204,482
shares
|
$32.2 Million
0.05% of portfolio
|
Q4 2024
Added 14.03%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
May 15, 2025 Q1 2025 |
199,264
shares
|
$31.3 Million
15.67% of portfolio
|
Q1 2025
Added 0.14%
|
|
|
Catalio Capital Management, LP
New York, NY |
May 15, 2025 Q1 2025 |
195,523
shares
|
$30.7 Million
7.41% of portfolio
|
Q1 2025
Reduced 9.31%
|
|
|
Allspring Global Investments Holdings, LLC
|
Apr 24, 2025 Q1 2025 |
189,613
shares
|
$29.8 Million
0.05% of portfolio
|
Q1 2025
Added 24.14%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
186,916
shares
|
$29.4 Million
2.33% of portfolio
|
Q1 2025
Added 256.76%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
185,122
shares
|
$29.1 Million
0.0% of portfolio
|
Q1 2025
Added 139.09%
|
|
|
Finepoint Capital LP
Boston, MA |
May 14, 2025 Q1 2025 |
179,872
shares
|
$28.3 Million
2.96% of portfolio
|
Q1 2025
Reduced 2.7%
|
|
|
Loomis Sayles & CO L P
|
May 14, 2025 Q1 2025 |
174,913
shares
|
$27.5 Million
0.04% of portfolio
|
Q1 2025
Reduced 2.23%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
173,841
shares
|
$27.3 Million
0.01% of portfolio
|
Q1 2025
Reduced 22.97%
|
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
171,731
shares
|
$27 Million
0.05% of portfolio
|
Q1 2025
Reduced 8.25%
|
|
|
Resolute Capital Asset Partners LLC
Denver, CO |
May 14, 2025 Q1 2025 |
167,500
shares
|
$26.3 Million
16.37% of portfolio
|
Q1 2025
Added 46.29%
|
|
|
Rice Hall James & Associates, LLC
|
May 01, 2025 Q1 2025 |
160,796
shares
|
$25.3 Million
1.64% of portfolio
|
Q1 2025
Reduced 1.89%
|
|
|
Stanley Druckenmiller
Duquesne Family Office LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
158,720
shares
|
$25 Million
0.81% of portfolio
|
Q1 2025
Reduced 40.11%
|